Latest Breaking News On - Biphasic low dose naltrexone - Page 1 : comparemela.com

/PRNewswire/ JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of.

United statesTony isaacTony giordanoAmol soinExchange commissionVitro study of developmentSociety best research abstract of the yearJanone incAmerican society of interventional pain physiciansResearch abstractAmerican societyInterventional pain physiciansChief medical officerVitro studyBiphasic low dose naltrexoneChief scientific